Ovesco Endoscopy AG fait un don de 3 314,05 euros à “Help for Sick Children”, ...

„Everyone is just talking about it – ovesco does it“ – thanks to ARKTIK, climate-neutral ...

Conference Report of the United European Gastroenterology Week (UEGW) 2019: OTSC® shows superio ...

A randomized controlled trial presented at the American College of Gastroenterology (ACG) meeti ...

Conference of the German Society of Gastroenterology, and Digestive and Metabolic Diseases with ...

Ovesco Endoscopy AG partnered in an innovative training network focusing on “Wireless in-body e ...

In 156 patients with histologic evidence of adenocarcinoma, EFTR was technically successful in ...

Ovesco Endoscopy is pleased to announce that the stentfix OTSC® System Set has received market ...

The Gastrointestinal Endoscopy Editorial Board chooses resection techniques namely EMR/submucos ...

EFTR in 30 patients with recurrent / residual colorectal neoplasia led to R0 resection in ...

The medical technology company located in Tuebingen will officially inaugurate its new building ...

The novel EMR+ technique uses an external additional working channel (AWC®) and a poloxamer age ...

When compared to fistulectomy and primary sphincter reconstruction, the OTSC Proctology showed ...

To err is human – to help is, too! Due to a missed exhibition stand ...

In 50 patients with complex benign esophageal stenoses, endoscopic bougienage with the BougieCa ...

For Ovesco Endoscopy AG, product innovation is among their core competences. Within the framewo ...

Gastric EFTR in 29 patients with gastric SET led to en-bloc resection in 89.7 %, ...

Digestive Disease Week – DDW 2019: – National and international multicenter studies confi ...

On the occasion of the 1st Family Day in the new building, the ovesco Endoscopy ...

German Coloproctology-Congress of the German Society for Coloproctology (Deutsche Gesellschaft ...

93 % primary hemostasis was achieved with primary OTSC therapy (288 patients), 91 % with ...

In lesions of 3 cm, EMR+ reaches its best discriminatory power: R0 resection rate of ...

Technical success (lesion reached and resected) was achieved in 94.4 %. R0 resection was achiev ...

Conference of the German Society for Endoscopy and Imaging Procedures (DGE-BV) 2019 together wi ...

After moving to its new company headquarters in the Technology Park Tuebingen at the beginning ...

Pooled durable clinical success proportions of OTSC use were 87.5 % in hemorrhage, 81.4 % ...

Ovesco Endoscopy AG emménagera dans son nouveau siège social le 29 avril 2019 et réunira ...

Prospective data from 51 FTRD-procedures shows technical success in 88 % (45/51) and a R0-resec ...

Ovesco is proud to announce that both the OTSC® System and the remOVE System including ...

6 consecutive T1-ERC patients underwent FTRD application which resulted in complete endoscopic ...

EFTR of duodenal lesions in 20 patients showed technical success in 17/20 (85.0 %), a ...

96.4 % hemostasis rate is reported from 286 emergency endoscopies for either upper or lower ...

Case series of 11 OTSC applications in 10 pediatric patients shows 100 % technical success ...

Italian single-center study of 20 consecutive patients with non-lifting lesions, adenoma recurr ...

Ovesco Endoscopy AG merges all business entities in the Americas into its Ovesco Endoscopy USA ...

OTSC use in patients with refractory gastrointestinal diseases achieved an overall clinical suc ...

In a multicentric cohort of 100 consecutive patients with mean age 72 y, 51 % ...

Stuttgart, December 11, 2018 – Three medical technology companies of Tübingen receive the famil ...